Pfizer quarterly revenue soars 19.7 per cent
The company's revenue rose to $13.01 billion in the first quarter, from $10.86 billion a year earlier.03-05-2016
03-05-2016
Pfizer to pay $785 mn for overcharging US govt on drugs
Under the Medicaid program, drug companies must report to the government the best prices they offer other customers for their brand-name drugs.28-04-2016
FY16 results on May 06, 2016
Pfizer Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 06, 2016, inter alia, to consider and take on record the Audited Financial Results of the Company for the quarter January 01, 2016 to March 31, 2016 and for the financial year ended March 31, 2016.At the said meeting, the Board of Directors will also consider recommendation of dividend, if any, for the financial year ended March 31, 2016....26-04-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Pfizer Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.16-04-2016
Shareholding for the Period Ended March 31, 2016
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here16-04-2016
Schedule of Analyst / Institutional Investor Meeting
Pfizer Ltd has informed BSE regarding "Schedule of Analyst / Institutional Investor Meeting".13-04-2016
Pfizer Announces Termination of Proposed Combination with Allergan
Pfizer Ltd has submitted to BSE a copy of Press Release dated April 06, 2016 titled 'Pfizer Announces Termination of Proposed Combination with Allergan'06-04-2016
Allergan, Pfizer call off proposed $160 billion merger
Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan.06-04-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Pfizer Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".30-03-2016
Thermo Fisher Scientific in agreement with Novartis and Pfizer
To develop and commercialise a multi-marker, universal next-generation sequencing oncology test29-03-2016